In HCT116, a colon cancer line, that carries a mutant KRAS allele, we find that interfering with the RAF effector axis at the level of RAF (BRAF and CRAF) and MEK (MEK1 and MEK2) was effective in delaying tumor growth. This evidence concerns the gene MAP2K1 and colonic neoplasm.